Skip Navigation



Carcinogenesis Advance Access published online on June 14, 2006

Carcinogenesis, doi:10.1093/carcin/bgl091
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary data
Right arrow All Versions of this Article:
28/1/49    most recent
bgl091v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pacher, M.
Right arrow Articles by Schreiber, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pacher, M.
Right arrow Articles by Schreiber, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
Received September 15, 2005
Revised May 19, 2006
Accepted May 20, 2006

CANCER BIOLOGY

Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells

Margit Pacher 1, Michael J. Seewald 2, Mario Mikula 3, Susanne Oehler 1, Maurice Mogg 1, Ursula Vinatzer 1, Andreas Eger 4, Norbert Schweifer 2, Roland Varecka 2, Wolfgang Sommergruber 2, Wolfgang Mikulits 3, and Martin Schreiber 1 *

1 Department of Obstetrics and Gynecology, Medical University of Vienna, A-1090 Vienna, Austria
2 Boehringer Ingelheim Austria, A-1120 Vienna, Austria
3 Department of Internal Medicine I, Medical University of Vienna, A-1090 Vienna, Austria
4 Department of Medical Biochemistry, Medical University of Vienna, A-1090 Vienna, Austria

* To whom correspondence should be addressed.
Martin Schreiber, E-mail: martin.schreiber{at}meduniwien.ac.at


   Abstract

Insulin-like growth factor (IGF) signaling is a key regulator of breast development and breast cancer. We have analyzed the expression of the IGF signaling cascade in 17 human breast cancer and 4 mammary epithelial cell lines. 5 cell lines expressed high levels of IGF1 receptor, insulin/IGF receptor substrate 1, IGF binding proteins 2 and 4, as well as the estrogen receptor, indicating a co-activation of IGF- and estrogen receptor signaling. Next, we stably overexpressed IGF1 and IGF2 in MCF7 breast cancer cells, which did not affect their epithelial characteristics and the expression and localization of the epithelial marker-genes E-cadherin and ß-catenin. Conversely, IGF1 and IGF2 overexpression potently increased cellular proliferation rates and the efficiency of tumor formation in mouse xenograft experiments, whereas the resistance to chemotherapeutic drugs such as taxol was unaltered. Expression profiling of overexpressing cells with whole-genome oligonucleotide microarrays revealed that 21 genes were up-regulated more than two-fold by both IGF1 and IGF2, 9 by IGF1, and 9 by IGF2. Half of the genes found to be up-regulated are involved in transport and biosynthesis of amino acids, including several amino acid transport proteins, argininosuccinat- and asparagine synthetases, and methionyl-tRNA synthetase. Up-regulation of these genes constitutes a novel mechanism apparently contributing to the stimulatory effects of IGF signaling on the global protein synthesis rate. We conclude that the induction of cell proliferation and tumor formation by long-term IGF stimulation may be primarily due to anabolic effects, in particular increased amino acid production and uptake.

Keywords: amino acid metabolism; DNA microarrays; expression profiling; IGF target genes; MCF7 breast cancer cells.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
N. K. Saxena, L. Taliaferro-Smith, B. B. Knight, D. Merlin, F. A. Anania, R. M. O'Regan, and D. Sharma
Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Factor Receptor
Cancer Res., December 1, 2008; 68(23): 9712 - 9722.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. J. Creighton, A. Casa, Z. Lazard, S. Huang, A. Tsimelzon, S. G. Hilsenbeck, C. K. Osborne, and A. V. Lee
Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis
J. Clin. Oncol., September 1, 2008; 26(25): 4078 - 4085.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. L. Deming, Z. Ren, Q. Cai, X.-O. Shu, W. Wen, J.-R. Long, Y.-T. Gao, and W. Zheng
IGF-I and IGF-II Genetic Variation and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 255 - 257.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.